Michael J. Mina, MD, PhD

Michael J. Mina, MD, PhD

Harvard University

H-index: 38

North America-United States

About Michael J. Mina, MD, PhD

Michael J. Mina, MD, PhD, With an exceptional h-index of 38 and a recent h-index of 34 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Assistant Professor, Infectious Disease Epidemiology, Immunology, Ecology, Clinical Pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia

The coronavirus disease 2019 rebound study: a prospective cohort study to evaluate viral and symptom rebound differences in participants treated with nirmatrelvir plus …

Assessing the effects of measles virus infections on childhood infectious disease mortality in Brazil

The paxlovid rebound study: a prospective cohort study to evaluate viral and symptom rebound differences between paxlovid and untreated COVID-19 participants

Real world performance of SARS-CoV-2 antigen rapid diagnostic tests in various clinical settings

Mathematical modeling to inform vaccination strategies and testing approaches for coronavirus disease 2019 (COVID-19) in nursing homes

High rates of rapid antigen test positivity after 5 days of isolation for COVID-19

Michael J. Mina, MD, PhD Information

University

Position

Harvard Medical School

Citations(all)

7627

Citations(since 2020)

7019

Cited By

2277

hIndex(all)

38

hIndex(since 2020)

34

i10Index(all)

61

i10Index(since 2020)

59

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Michael J. Mina, MD, PhD Skills & Research Interests

Assistant Professor

Infectious Disease Epidemiology

Immunology

Ecology

Clinical Pathology

Top articles of Michael J. Mina, MD, PhD

Title

Journal

Author(s)

Publication Date

Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis

JAMA neurology

Marianna Cortese

Yumei Leng

Kjetil Bjornevik

Moriah Mitchell

Brian C Healy

...

2024/3/18

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia

Plos one

Nila J Dharan

Sarah C Sasson

Golo Ahlenstiel

Christopher R Andersen

Mark Bloch

...

2023/11/1

The coronavirus disease 2019 rebound study: a prospective cohort study to evaluate viral and symptom rebound differences in participants treated with nirmatrelvir plus …

Clinical Infectious Diseases

Jay A Pandit

Jennifer M Radin

Danielle C Chiang

Emily G Spencer

Jeff B Pawelek

...

2023/7/1

Assessing the effects of measles virus infections on childhood infectious disease mortality in Brazil

The Journal of infectious diseases

Siyang Xia

Cricket C Gullickson

C Jessica E Metcalf

Bryan T Grenfell

Michael J Mina

2023/1/1

The paxlovid rebound study: a prospective cohort study to evaluate viral and symptom rebound differences between paxlovid and untreated COVID-19 participants

medRxiv

Jay A Pandit

Jennifer M Radin

Danielle Chiang

Emily Spencer

Jeff Pawelek

...

2022/11/15

Real world performance of SARS-CoV-2 antigen rapid diagnostic tests in various clinical settings

Infection Control & Hospital Epidemiology

Gili Regev-Yochay

Or Kriger

Michael J Mina

Sharon Beni

Carmit Rubin

...

2022/3/2

Mathematical modeling to inform vaccination strategies and testing approaches for coronavirus disease 2019 (COVID-19) in nursing homes

Clinical Infectious Diseases

Rebecca Kahn

Inga Holmdahl

Sujan Reddy

John Jernigan

Michael J Mina

...

2022/2/15

High rates of rapid antigen test positivity after 5 days of isolation for COVID-19

MedRxiv

Emily Landon

Allison H Bartlett

Rachel Marrs

Caroline Guenette

Stephen G Weber

...

2022/2/2

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Science

Kjetil Bjornevik

Marianna Cortese

Brian C Healy

Jens Kuhle

Michael J Mina

...

2022/1/21

Economic benefits of covid-19 screening tests with a vaccine rollout

medRxiv

Andrew Atkeson

Michael Droste

Michael J Mina

James H Stock

2021/3/5

Partial immunity and SARS-CoV-2 mutations—Response

Science

Chadi M Saad-Roy

Sinead E Morris

C Jessica E Metcalf

Michael J Mina

Rachel E Baker

...

2021/4/23

Viral loads observed under competing strain dynamics

MedRxiv

James A Hay

Lee Kennedy-Shaffer

Michael J Mina

2021/7/30

Cross-sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities

The Journal of Infectious Diseases

Niall J Lennon

Roby P Bhattacharyya

Michael J Mina

Heidi L Rehm

Deborah T Hung

...

2021/11/15

Estimating internationally imported cases during the early COVID-19 pandemic

Nature communications

Tigist F Menkir

Taylor Chin

James A Hay

Erik D Surface

Pablo M De Salazar

...

2021/1/12

Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program

European Journal of Epidemiology

Jaap Goudsmit

Anita Huiberdina Johanna van den Biggelaar

Wouter Koudstaal

Albert Hofman

Wayne Chester Koff

...

2021/7

Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes

Science

Chadi M Saad-Roy

Sinead E Morris

C Jessica E Metcalf

Michael J Mina

Rachel E Baker

...

2021/4/23

Development of at-home sample collection logistics for large-scale seroprevalence studies

Plos One

Michael J. Mina Aishani V. Aatresh

Kate Cummings

Hilary Gerstein

Christopher S. Knight

Andreas Limberopolous

...

2021/11/4

Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction

Science

Scott B Biering

David L Akey

Marcus P Wong

W Clay Brown

Nicholas TN Lo

...

2021/1/8

Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19

The Lancet

Michael J Mina

Tim E Peto

Marta García-Fiñana

Malcolm G Semple

Iain E Buchan

2021/4/17

Estimating epidemiologic dynamics from cross-sectional viral load distributions

Science

James A Hay

Lee Kennedy-Shaffer

Sanjat Kanjilal

Niall J Lennon

Stacey B Gabriel

...

2021/6/3

See List of Professors in Michael J. Mina, MD, PhD University(Harvard University)

Co-Authors

H-index: 113
Bryan Grenfell

Bryan Grenfell

Princeton University

H-index: 65
C. Jessica E. Metcalf

C. Jessica E. Metcalf

Princeton University

academic-engine